Skip to main content
. Author manuscript; available in PMC: 2023 Dec 22.
Published in final edited form as: Vaccine. 2014 Mar 11;32(20):2315–2320. doi: 10.1016/j.vaccine.2014.02.067

Table 1d.

Countries with the highest pertussis incidence, 2008–2012.

Country Total pertussis case count, 2008–2012 JRF Annualized pertussis incidence, 2008–2012, per 1000 populationa Estimated DTP3 coverageb, 2010 GNI, ($), 2010c

Australia 140,160 1.26 92 (92) 46,320
Norway 20,930 0.86 93 (93) 86,850
Papua New Guinea 18,978 0.55 56 (70) 1300
Netherlands 38,053 0.46 97 (97) 48,580
Estonia 3036 0.45 94 (94) 14,150
New Zealand 8708 0.40 93 (93) 28,310
Switzerland 14,300 0.37 96 (96) 73,350
Israel 9670 0.26 94 (NA) 27,270
Somalia 8300 0.18 45 (64) NA
Slovenia 1695 0.17 96 (96) 23,910

The bold value represents the column which was used to select the countries that are listed in the table.

a

Annual incidence is calculated as the number of pertussis cases reported on the 2012 JRF [7] divided by the WHO population estimate for the associated country [11] (In Table 1d, the 5 year total incidence was divided by 5, to represent average annual incidence).

b

UNICEF/WHO estimate of DTP3 coverage [9]. Numbers in parentheses represent country official figures on theJRF.

c

GNI = World Bank Gross National Income percapita, Atlas method [10] (*estimate from 2011, †estimate from 2010).